98%
921
2 minutes
20
Objectives: Robust evidence supports optimism as an asset for good physical and emotional health in aging populations, but its role in cognitive aging remains understudied. This study evaluated whether higher optimism levels would be prospectively associated with higher initial levels and slower decline in cognitive functioning over 26 years in a community-dwelling cohort of aging men.
Methods: Participants included 847 men from the Veterans Affairs Normative Aging Study who completed the Revised Optimism-Pessimism scale of the Minnesota Multiphasic Personality Inventory-2 in 1986 and ≥1 cognitive assessment repeated triennially in 1993-2019. At each assessment, scores from 7 cognitive tests were combined into a global composite and 3 domain-specific composites: verbal memory, executive functioning, and visuospatial ability. Mixed-effects regression models evaluated the associations between optimism and cognitive trajectories.
Results: Higher optimism levels were associated with higher initial levels but not less decline in global cognitive functioning over time (B = 0.04, 95%CI: 0.001, 0.07), adjusted for demographics, practice effects, and lag between optimism assessment and the first cognitive assessment. In domain-specific analyses, optimism was associated with higher initial levels but not magnitude of decline in verbal memory (B = 0.06, 95%CI: 0.01, 0.12), and unrelated to executive functioning or visuospatial ability trajectories.
Discussion: This study adds specificity to a nascent literature linking optimism to cognitive aging, indicating an association with initial levels, but not decline-particularly in verbal memory-in older men. Examining these relationships earlier in life may further clarify the etiologic role of optimism in cognitive health across the developmental span.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/geronb/gbaf139 | DOI Listing |
QJM
September 2025
Senior resident, Department of Endocrinology & Metabolism, Medical College & Hospital, Kolkata, India.
This paper explores the intricate relationship between love, sexuality, and the emerging realm of Artificial Intelligence (AI) through an interdisciplinary lens encompassing psychological, neurological, and endocrinological frameworks. By dissecting love as a multifaceted construct-rooted in attachment, emotion, and interdependence-and analyzing its convergence with sexuality, the study proposes a refined model of romantic bonding. Emphasizing the potential pitfalls of love mimickers such as obsession, possession, and paranoia, the paper also considers how personality traits and sociocultural influences affect couple dynamics.
View Article and Find Full Text PDFClin Pract
July 2025
Institute of Occupational Medicine, Social Medicine and Environmental Medicine, Goethe University Frankfurt, 60590 Frankfurt, Germany.
: Artificial intelligence (AI) is being increasingly promoted as a means to enhance diagnostic accuracy, to streamline workflows, and to improve overall care quality in primary care. However, empirical evidence on how primary care physicians (PCPs) perceive, engage with, and emotionally respond to AI technologies in everyday clinical settings remains limited. Concerns persist regarding AI's usability, transparency, and potential impact on professional identity, workload, and the physician-patient relationship.
View Article and Find Full Text PDFPsychooncology
August 2025
Department of Psychology, University of Miami, Coral Gables, Florida, USA.
Background: Women prescribed adjuvant endocrine therapy (AET) for nonmetastatic breast cancer may experience a decline in positive psychological well-being (PPWB) and self-efficacy. Brief cognitive behavioral therapy (CBT) and relaxation training (RT) interventions have shown short-term efficacy in reducing distress, but their impact on PPWB and self-efficacy over longer periods among women prescribed AET is unknown.
Aims: We aimed to investigate longitudinal effects of CBT and RT on PPWB and self-efficacy among women prescribed AET.
Prog Brain Res
August 2025
Laboratory of Molecular and Functional Neurobiology, University of São Paulo, São Paulo, Brazil. Electronic address:
Recent data underscores a critical public health issue: more than 40 % of the global population suffers from neurological conditions, for which no cures currently exist. To combat this pressing challenge, researchers are turning to phytochemicals-bioactive compounds derived from plants that hold promising health benefits, particularly for cognitive function. This chapter intends to shed light on groundbreaking discoveries regarding curcumin, isoflavonoids, and cardiotonic steroids, natural compounds that act on the brain.
View Article and Find Full Text PDF